Papers/PMID:38444016
The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial.
Nutrition journal2024The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
(R)-carnitine — decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The results of the chi-square test revealed that the 28-day mortality rate was lower in the intervention group in comparison to the control group (7 persons (23.33%) vs. 15 persons (50.00%), p-value: 0.032).”
Quoted verbatim from The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial.. - Study
- RCT
- Duration
- 7 days
- Dose
- L-carnitine 3 g/day (1 g three times daily) for 7 days
- Population
- Critically ill adult patients with sepsis in a general ICU, enterally fed, receiving standard treatment in both arms; 28-day follow-up by telephone
The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial.2024PMID:38444016Permalink